title: Multiple roles of the extracellular vestibule amino acid residues in the function of the rat P2X4 receptor.
abstract: The binding of ATP to trimeric P2X receptors (P2XR) causes an enlargement of the receptor extracellular vestibule, leading to opening of the cation-selective transmembrane pore, but specific roles of vestibule amino acid residues in receptor activation have not been evaluated systematically. In this study, alanine or cysteine scanning mutagenesis of V47-V61 and F324-N338 sequences of rat P2X4R revealed that V49, Y54, Q55, F324, and G325 mutants were poorly responsive to ATP and trafficking was only affected by the V49 mutation. The Y54F and Y54W mutations, but not the Y54L mutation, rescued receptor function, suggesting that an aromatic residue is important at this position. Furthermore, the Y54A and Y54C receptor function was partially rescued by ivermectin, a positive allosteric modulator of P2X4R, suggesting a rightward shift in the potency of ATP to activate P2X4R. The Q55T, Q55N, Q55E, and Q55K mutations resulted in non-responsive receptors and only the Q55E mutant was ivermectin-sensitive. The F324L, F324Y, and F324W mutations also rescued receptor function partially or completely, ivermectin action on channel gating was preserved in all mutants, and changes in ATP responsiveness correlated with the hydrophobicity and side chain volume of the substituent. The G325P mutant had a normal response to ATP, suggesting that G325 is a flexible hinge. A topological analysis revealed that the G325 and F324 residues disrupt a β-sheet upon ATP binding. These results indicate multiple roles of the extracellular vestibule amino acid residues in the P2X4R function: the V49 residue is important for receptor trafficking to plasma membrane, the Y54 and Q55 residues play a critical role in channel gating and the F324 and G325 residues are critical for vestibule widening.
authors.affiliation: Department of Cellular and Molecular Neuroendocrinology, Institute of Physiology of the Academy of Sciences of the Czech Republic, Prague, Czech Republic. rokic@biomed.cas.cz
authors.forename: Milos B
authors.initials: MB
authors.lastname: Rokic
authors.forename: Stanko S
authors.initials: SS
authors.lastname: Stojilkovic
authors.forename: Vojtech
authors.initials: V
authors.lastname: Vavra
authors.forename: Pavlo
authors.initials: P
authors.lastname: Kuzyk
authors.forename: Vendula
authors.initials: V
authors.lastname: Tvrdonova
authors.forename: Hana
authors.initials: H
authors.lastname: Zemkova
mesh_terms: D000255:Adenosine Triphosphate / Q000737:chemistry* / Q000378:metabolism; D000494:Allosteric Regulation; D000596:Amino Acids / Q000737:chemistry* / Q000235:genetics / Q000378:metabolism; D000818:Animals; D057809:HEK293 Cells; D006801:Humans; D057927:Hydrophobic and Hydrophilic Interactions; D015640:Ion Channel Gating / Q000187:drug effects / Q000502:physiology*; D007559:Ivermectin / Q000737:chemistry / Q000494:pharmacology; D008958:Models, Molecular; D016297:Mutagenesis, Site-Directed; D018408:Patch-Clamp Techniques; D017354:Point Mutation; D017433:Protein Structure, Secondary; D051381:Rats; D058848:Receptors, Purinergic P2X4 / Q000737:chemistry* / Q000235:genetics / Q000378:metabolism; D013329:Structure-Activity Relationship; D014162:Transfection
chemical_list: D000596:Amino Acids; D058848:Receptors, Purinergic P2X4; D007559:Ivermectin; D000255:Adenosine Triphosphate
references.citation: J Biol Chem. 2000 Nov 3;275(44):34190-6
references.pmid: 10940304
references.citation: J Biol Chem. 2012 Mar 2;287(10):7594-602
references.pmid: 22219189
references.citation: Purinergic Signal. 2012 Sep;8(3):375-417
references.pmid: 22547202
references.citation: J Neurosci. 2007 Apr 11;27(15):4072-82
references.pmid: 17428985
references.citation: Nature. 2007 Jul 12;448(7150):200-3
references.pmid: 17625565
references.citation: EMBO J. 1996 Jan 2;15(1):55-62
references.pmid: 8598206
references.citation: Neuroscience. 2011 Aug 11;188:1-12
references.pmid: 21575687
references.citation: J Neurochem. 2009 May;109(3):923-34
references.pmid: 19425179
references.citation: J Biol Chem. 2002 Sep 20;277(38):35378-85
references.pmid: 12105201
references.citation: Trends Endocrinol Metab. 2009 Nov;20(9):460-8
references.pmid: 19800813
references.citation: Pharmacol Rev. 2006 Mar;58(1):58-86
references.pmid: 16507883
references.citation: Biochem Biophys Res Commun. 2006 Oct 20;349(2):619-25
references.pmid: 16949036
references.citation: J Neurochem. 2008 May;105(4):1264-75
references.pmid: 18194442
references.citation: J Am Chem Soc. 2012 Oct 10;134(40):16536-9
references.pmid: 22989233
references.citation: J Biol Chem. 2010 Mar 26;285(13):10110-10121
references.pmid: 20093367
references.citation: J Biol Chem. 2003 Sep 19;278(38):36777-85
references.pmid: 12819199
references.citation: J Gen Physiol. 2004 Mar;123(3):281-93
references.pmid: 14769846
references.citation: J Neurosci. 2002 Jun 15;22(12):4814-24
references.pmid: 12077178
references.citation: J Gen Physiol. 2011 Jun;137(6):579-90
references.pmid: 21624948
references.citation: J Cell Sci. 2007 Nov 1;120(Pt 21):3838-49
references.pmid: 17940064
references.citation: J Biol Chem. 2006 Oct 27;281(43):32649-59
references.pmid: 16954225
references.citation: J Biol Chem. 2011 Aug 19;286(33):29207-29217
references.pmid: 21690089
references.citation: Proc Natl Acad Sci U S A. 2011 Aug 16;108(33):13800-5
references.pmid: 21808018
references.citation: Annu Rev Physiol. 2009;71:333-59
references.pmid: 18851707
references.citation: J Pharmacol Sci. 2004 Feb;94(2):112-4
references.pmid: 14978347
references.citation: J Neurosci. 2004 Mar 31;24(13):3413-20
references.pmid: 15056721
references.citation: Cell Mol Neurobiol. 2010 Nov;30(8):1251-8
references.pmid: 21107680
references.citation: Nature. 2012 May 10;485(7397):207-12
references.pmid: 22535247
references.citation: J Neurosci. 2007 Feb 7;27(6):1456-66
references.pmid: 17287520
references.citation: J Biol Chem. 2008 Feb 22;283(8):5110-7
references.pmid: 18048351
references.citation: J Neurochem. 2006 Feb;96(3):843-52
references.pmid: 16371009
references.citation: J Neurosci. 2009 Nov 11;29(45):14257-64
references.pmid: 19906973
references.citation: Proc Natl Acad Sci U S A. 2012 Mar 13;109(11):4140-5
references.pmid: 22378652
references.citation: Neuron. 2012 Oct 4;76(1):51-69
references.pmid: 23040806
references.citation: J Gen Physiol. 2007 Mar;129(3):245-56
references.pmid: 17325195
references.citation: J Neurochem. 2005 Dec;95(6):1746-54
references.pmid: 16236030
references.citation: J Gen Physiol. 2005 Apr;125(4):347-59
references.pmid: 15795310
references.citation: J Biol Chem. 2005 Feb 18;280(7):6118-29
references.pmid: 15556949
references.citation: Physiol Rev. 2002 Oct;82(4):1013-67
references.pmid: 12270951
references.citation: Neurosci Lett. 2000 Dec 8;295(3):77-80
references.pmid: 11090978
references.citation: Eur J Neurosci. 2011 Apr;33(7):1175-1185
references.pmid: 21324005
references.citation: Pharmacol Rev. 2011 Sep;63(3):641-83
references.pmid: 21737531
references.citation: EMBO J. 1997 Jun 16;16(12):3446-54
references.pmid: 9218787
references.citation: J Biol Chem. 2001 May 4;276(18):14902-8
references.pmid: 11278888
references.citation: EMBO J. 1998 Jun 1;17(11):3016-28
references.pmid: 9606184
references.citation: J Neurosci. 1999 Sep 1;19(17):7289-99
references.pmid: 10460235
references.citation: J Biol Chem. 2004 Mar 5;279(10):9043-55
references.pmid: 14699168
references.citation: J Neurosci. 2004 Aug 18;24(33):7378-86
references.pmid: 15317863
references.citation: Nat Neurosci. 1999 Apr;2(4):322-30
references.pmid: 10204538
references.citation: J Neurochem. 2010 Jan;112(1):307-17
references.pmid: 19878433
references.citation: Nat Neurosci. 1999 Apr;2(4):315-21
references.pmid: 10204537
references.citation: Nature. 2009 Jul 30;460(7255):592-8
references.pmid: 19641588